Biosimilar workflow growing at CDER

FDA's Center for Drug Evaluation and Research on Tuesday told BioCentury it has received 78 requests for initial meetings to discuss biosimilar development programs for 14 different reference products. CDER also said it has held 63 initial meetings with biosimilar sponsors.

In April, the center reported it had received 67 meeting requests and had held 55 meetings. ...